Jill Ashton

Jill Ashton is an accomplished professional with extensive experience in oncology and business development. Currently serving as the Director of Business Development at MiBA since April 2024, Jill partners with Pharma & Biotech, Payers, and Practices to enhance oncology outcomes through comprehensive data solutions. Previously, Jill held the position of Director of Strategic Accounts at GSK from October 2019 to April 2024, focusing on strategy development and innovative partnerships in oncology. Early career roles include Oncology Account Manager positions at Acrotech Biopharma and Spectrum Pharmaceuticals, where Jill achieved top national rankings and led successful product launches. Jill also excelled as an Immunotherapy Sales Specialist at Dendreon and as an Oncology Clinical Specialist at Amgen. Jill began the career as an Oncology Nurse, progressing to Nursing Manager at Carle Foundation Hospital. Jill holds a BSN in Nursing from Murray State University.